Explore Neuropilin 1/NRP1/CD304 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
This gene encodes one of two neuropilins, which contain specific protein domains which allow them to participate in several different types of signaling pathways that control cell migration. Neuropilins contain a large N-terminal extracellular domain, made up of complement-binding, coagulation factor V/VIII, and meprin domains. These proteins also contains a short membrane-spanning domain and a small cytoplasmic domain. Neuropilins bind many ligands and various types of co-receptors; they affect cell survival, migration, and attraction. Some of the ligands and co-receptors bound by neuropilins are vascular endothelial growth factor (VEGF) and semaphorin family members. This protein has also been determined to act as a co-receptor for SARS-CoV-2 (which causes COVID-19) to infect host cells. [provided by RefSeq, Nov 2020]
| Target ID |
GM-T15023
|
| Target Name |
Neuropilin 1/NRP1/CD304
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
8829
|
| Gene ID |
100060430 (Equus caballus), 101094027 (Felis catus), 18186 (Mus musculus), 246331 (Rattus norvegicus) 477955 (Canis lupus familiaris), 539369 (Bos taurus), 697755 (Macaca mulatta), 8829 (Homo sapiens)
|
| Target Alternative Names |
BDCA4,C530029I03,CD304,NP-1,NP1,NPN-1,NRP,NRP1,Neuropilin 1,Neuropilin-1,Npn1,Nrp,Nrp1,VEGF165R,Vascular endothelial cell growth factor 165 receptor
|
| Uniprot Accession |
P97333,Q9QWJ9,O14786
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target, INN Index
|
| Disease |
cancer
|
| Disease from KEGG |
Axon guidance, Human T-cell leukemia virus 1 infection
|
| Gene Ensembl |
ENSECAG00000020753, ENSMUSG00000025810, ENSCAFG00845002787, ENSBTAG00000019866, ENSMMUG00000017588, ENSG00000099250
|
| Target Classification |
Tumor-associated antigen (TAA)
|
Pre-made viral vector of Neuropilin 1/NRP1/CD304 cDNA Clones/ORF Plasmid
Neuropilin 1/NRP1/CD304 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo8829 | Pre-made Human NRP1/NP1/NRP siRNA oligo Duplex | 8829 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo246331 | Pre-made Rat Nrp1/Nrp siRNA oligo Duplex | 246331 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo18186 | Pre-made Mouse Nrp1/Nrp/NP-1 siRNA oligo Duplex | 18186 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo697755 | Pre-made Cynomolgus/Rhesus macaque NRP1 siRNA oligo Duplex | 697755 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101094027 | Pre-made Cat/Feline NRP1 siRNA oligo Duplex | 101094027 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo477955 | Pre-made Dog/Canine NRP1 siRNA oligo Duplex | 477955 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo539369 | Pre-made Bovines/Cattle NRP1 siRNA oligo Duplex | 539369 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100060430 | Pre-made Equine/Horse NRP1 siRNA oligo Duplex | 100060430 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
Neuropilin 1/NRP1/CD304 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T15023-Ab | Human | Anti-Human Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T15023-Ab | Rat | Anti-Rat Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T15023-Ab | Mouse | Anti-Mouse Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T15023-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T15023-Ab | Cat/Feline | Anti-Cat/Feline Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T15023-Ab | Dog/Canine | Anti-Dog/Canine Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T15023-Ab | Bovines/Cattle | Anti-Bovines/Cattle Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T15023-Ab | Equine/Horse | Anti-Equine/Horse Neuropilin 1/NRP1/CD304 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
Neuropilin 1/NRP1/CD304 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T15023-Ag | Human | Human Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T15023-Ag | Rat | Rat Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T15023-Ag | Mouse | Mouse Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T15023-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T15023-Ag | Cat/Feline | Cat/Feline Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T15023-Ag | Dog/Canine | Dog/Canine Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T15023-Ag | Bovines/Cattle | Bovines/Cattle Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T15023-Ag | Equine/Horse | Equine/Horse Neuropilin 1/NRP1/CD304 VLP (virus-like particle) | HEK293 | Products Developing |